These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 33930050)

  • 1. Budget impact analysis of using procalcitonin to optimize antimicrobial treatment for patients with suspected sepsis in the intensive care unit and hospitalized lower respiratory tract infections in Argentina.
    Garay OU; Guiñazú G; Cornistein W; Farina J; Valentini R; Levy Hara G
    PLoS One; 2021; 16(4):e0250711. PubMed ID: 33930050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cost impact of PCT-guided antibiotic stewardship versus usual care for hospitalised patients with suspected sepsis or lower respiratory tract infections in the US: A health economic model analysis.
    Mewes JC; Pulia MS; Mansour MK; Broyles MR; Nguyen HB; Steuten LM
    PLoS One; 2019; 14(4):e0214222. PubMed ID: 31013271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The budget impact of procalcitonin-guided antibiotic stewardship compared to standard of care for patients with suspected sepsis admitted to the intensive care unit in Belgium.
    Garnfeldt VM; Vincent JL; Gruson D; Garay OU; Vansieleghem S; Iniguez L; Lefevre A
    PLoS One; 2023; 18(10):e0293544. PubMed ID: 37903106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-Effectiveness Analysis of a Procalcitonin-Guided Decision Algorithm for Antibiotic Stewardship Using Real-World U.S. Hospital Data.
    Voermans AM; Mewes JC; Broyles MR; Steuten LMG
    OMICS; 2019 Oct; 23(10):508-515. PubMed ID: 31509068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Procalcitonin testing to guide antibiotic therapy for the treatment of sepsis in intensive care settings and for suspected bacterial infection in emergency department settings: a systematic review and cost-effectiveness analysis.
    Westwood M; Ramaekers B; Whiting P; Tomini F; Joore M; Armstrong N; Ryder S; Stirk L; Severens J; Kleijnen J
    Health Technol Assess; 2015 Nov; 19(96):v-xxv, 1-236. PubMed ID: 26569153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Procalcitonin to Reduce Long-Term Infection-associated Adverse Events in Sepsis. A Randomized Trial.
    Kyriazopoulou E; Liaskou-Antoniou L; Adamis G; Panagaki A; Melachroinopoulos N; Drakou E; Marousis K; Chrysos G; Spyrou A; Alexiou N; Symbardi S; Alexiou Z; Lagou S; Kolonia V; Gkavogianni T; Kyprianou M; Anagnostopoulos I; Poulakou G; Lada M; Makina A; Roulia E; Koupetori M; Apostolopoulos V; Petrou D; Nitsotolis T; Antoniadou A; Giamarellos-Bourboulis EJ
    Am J Respir Crit Care Med; 2021 Jan; 203(2):202-210. PubMed ID: 32757963
    [No Abstract]   [Full Text] [Related]  

  • 7. Analysis to determine cost-effectiveness of procalcitonin-guided antibiotic use in adult patients with suspected bacterial infection and sepsis.
    Collins CD; Brockhaus K; Sim T; Suneja A; Malani AN
    Am J Health Syst Pharm; 2019 Aug; 76(16):1219-1225. PubMed ID: 31369118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Observational multi-centre, prospective study to characterize novel pathogen-and host-related factors in hospitalized patients with lower respiratory tract infections and/or sepsis - the "TAILORED-Treatment" study.
    van Houten CB; Oved K; Eden E; Cohen A; Engelhard D; Boers S; Kraaij R; Karlsson R; Fernandez D; Gonzalez E; Li Y; Stubbs A; Moore ERB; Hays JP; Bont LJ
    BMC Infect Dis; 2018 Aug; 18(1):377. PubMed ID: 30086729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A PCT algorithm for discontinuation of antibiotic therapy is a cost-effective way to reduce antibiotic exposure in adult intensive care patients with sepsis.
    Kip MM; Kusters R; IJzerman MJ; Steuten LM
    J Med Econ; 2015; 18(11):944-53. PubMed ID: 26105574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of biomarkers to individualize antimicrobial therapy duration: a narrative review.
    Scott J; Deresinski S
    Clin Microbiol Infect; 2023 Feb; 29(2):160-164. PubMed ID: 36096429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Procalcitonin (PCT)-guided antibiotic stewardship in Asia-Pacific countries: adaptation based on an expert consensus meeting.
    Lee CC; Kwa ALH; Apisarnthanarak A; Feng JY; Gluck EH; Ito A; Karuniawati A; Periyasamy P; Pratumvinit B; Sharma J; Solante R; Swaminathan S; Tyagi N; Vu DM; Zirpe K; Schuetz P
    Clin Chem Lab Med; 2020 Nov; 58(12):1983-1991. PubMed ID: 31926074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Procalcitonin-guided antibiotic therapy: a systematic review and meta-analysis.
    Soni NJ; Samson DJ; Galaydick JL; Vats V; Huang ES; Aronson N; Pitrak DL
    J Hosp Med; 2013 Sep; 8(9):530-40. PubMed ID: 23955852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is Procalcitonin Biomarker-Guided Antibiotic Therapy a Cost-Effective Approach to Reduce Antibiotic Resistant and Clostridium difficile Infections in Hospitalized Patients?
    Steuten L; Mewes J; Lepage-Nefkens I; Vrijhoef H
    OMICS; 2018 Sep; 22(9):616-625. PubMed ID: 30235108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is procalcitonin-guided antimicrobial use cost-effective in adult patients with suspected bacterial infection and sepsis?
    Harrison M; Collins CD
    Infect Control Hosp Epidemiol; 2015 Mar; 36(3):265-72. PubMed ID: 25695167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections.
    Schuetz P; Müller B; Christ-Crain M; Stolz D; Tamm M; Bouadma L; Luyt CE; Wolff M; Chastre J; Tubach F; Kristoffersen KB; Burkhardt O; Welte T; Schroeder S; Nobre V; Wei L; Bhatnagar N; Bucher HC; Briel M
    Evid Based Child Health; 2013 Jul; 8(4):1297-371. PubMed ID: 23877944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of procalcitonin-guided antibiotic treatment on clinical outcomes in intensive care unit patients with infection and sepsis patients: a patient-level meta-analysis of randomized trials.
    Wirz Y; Meier MA; Bouadma L; Luyt CE; Wolff M; Chastre J; Tubach F; Schroeder S; Nobre V; Annane D; Reinhart K; Damas P; Nijsten M; Shajiei A; deLange DW; Deliberato RO; Oliveira CF; Shehabi Y; van Oers JAH; Beishuizen A; Girbes ARJ; de Jong E; Mueller B; Schuetz P
    Crit Care; 2018 Aug; 22(1):191. PubMed ID: 30111341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased antibiotic exposure using a procalcitonin protocol for respiratory infections and sepsis in US community hospitals (ProCommunity).
    DeSear KE; Thompson-Leduc P; Van Schooneveld TC; Kirson N; Chritton JJ; Ie S; Cheung HC; Ou S; Zimmer L; Schuetz P
    Curr Med Res Opin; 2021 May; 37(5):727-733. PubMed ID: 33617362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ineffectiveness of procalcitonin-guided antibiotic therapy in severely critically ill patients: A meta-analysis.
    Peng F; Chang W; Xie JF; Sun Q; Qiu HB; Yang Y
    Int J Infect Dis; 2019 Aug; 85():158-166. PubMed ID: 31229612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How to: implement procalcitonin testing in my practice.
    Neeser O; Branche A; Mueller B; Schuetz P
    Clin Microbiol Infect; 2019 Oct; 25(10):1226-1230. PubMed ID: 30616016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Procalcitonin-guided antibiotic therapy for suspected and confirmed sepsis of patients in a surgical trauma ICU: a prospective, two period cross-over, interventional study.
    Chomba RN; Moeng MS; Lowman W
    S Afr J Surg; 2020 Sep; 5(3):143-149. PubMed ID: 33231007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.